Founding partner of Chiron Biotech unveils novel options for bone tissue scaffolding applications

CONCR3DE, Dutch pioneer in binder jetting 3D printing, is set to present the latest advances in bioprinting at the upcoming BioCAM, from 6 to 8 December 2023 in Mons, Belgium. BioCAM is organized by the Belgian Ceramic Research Centre (INISMa) and the European Ceramic Society (ECerS) to showcase additive manufacturing applied to BioCeramics. In its capacity as founding partner of the Chiron Biotech project, CONCR3DE will present the findings of a joint Chiron Biotech study named ‘Binder jetting 3D printing of porous Poly (L-lactic acid) - hydroxyapatite scaffolds intended for use in bone tissue engineering applications’.

Farid Salari, research and development engineer at CONCR3DE, is excited to share the results. “Our ability to use low-temperature binder jetting technology to accurately print hydroxyapatite composite unlocks a range of new applications in creating scaffolds for bone tissue engineering.” By combining a bioresorbable medical grade polymer, specifically compounded PLLA-HA and CONCR3DE’s water-soluble Bio Binder with custom print parameters and a specific post-processing procedure, the team was able to obtain the mechanical properties, shape accuracy and strength to create unprecedented cylindrical shape scaffolds. Mr. Salari further explains the significance of this development: “The utilization of optimal printing parameters developed in this study can potentially enhance the structural, mechanical, and biological performances of PLLA-HA-based 3D scaffolds manufactured through the binder jetting 3D printing process.” The scaffolds are explicitly intended for application in bone and cartilage tissue engineering.

Are you interested to learn more about the study results, the hydroxyapatite composite material or the 3D printer hardware used? CONCR3DE invites interested parties to visit BioCAM on December 6th and attend Farid Salari’s presentation at 11:45 AM. Leave us a message with your contact details to receive the early bird rate for your registration. Offer ends Monday, December 4th 2023.

Chiron Biotech is a research project that aims to create the future of bioprinting. It works on creating a smart, multi-material 3D printing platform, including a portfolio of biomaterials and applications, both for research and production in the biomedical sector. The Chiron project was founded as an international collaboration between two enterprises, CONCR3DE and IPC,Innovative Polymer Compounds, and two research centers, the University Medical Center Utrecht and Trinity College Dublin. Chiron Biotech is funded by Eurostars, a European program dedicated to small and medium-sized enterprises (SMEs) performing research and development. Eurostars stimulates companies to set up and lead international collaborative research and innovation projects. The program is market-driven, focusses on the needs of SMEs and specifically targets the development of new products, processes, and services, as well as the access to transnational and international markets.

Would you like to know more? Contact our team today!